Polymorphisms associated with sickle cell disease in Southern Iran.
S Haghpanah1, S Nasirabadi, M Kianmehr
1Hematology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran.
Genetika
|September 20, 2012
Summary
This study explored sickle cell disease (SCD) BS-globin gene haplotypes in Southern Iran. No significant association was found between these haplotypes and the clinical severity of SCD in the Iranian population.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Sickle cell disease (SCD) is a significant inherited blood disorder.
- Understanding genetic factors like BS-globin gene haplotypes is crucial for disease management.
- Previous research has suggested potential links between haplotypes and SCD phenotypes.
Purpose of the Study:
- To characterize the spectrum of BS-globin gene haplotypes in SCD patients in Southern Iran.
- To investigate the relationship between these haplotypes and the clinical severity of SCD.
- To contribute to the understanding of SCD genetic variability in diverse populations.
Main Methods:
- Retrospective analysis of patient data.
- Haplotype analysis of the BS-globin gene.
- Correlation of haplotype data with clinical severity scores.
Main Results:
- The study described the spectrum of BS-globin gene haplotypes in the studied Iranian population.
- No statistically significant association was identified between specific BS-globin gene haplotypes and the clinical severity of sickle cell disease.
- The findings suggest that other genetic or environmental factors may play a more dominant role in modulating SCD phenotype in this region.
Conclusions:
- BS-globin gene haplotypes do not appear to be a significant determinant of clinical severity in SCD patients in Southern Iran.
- Further molecular-level studies with larger sample sizes are needed to elucidate the complex mechanisms influencing SCD presentation in the Iranian population.
- These findings highlight the need for population-specific genetic investigations in SCD research.
Related Concept Videos
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...